Collaboratively hosted by the ASQ Biomedical Division/New England Discussion Group, MassMEDIC and RAPS, FDA Update brings area medtech regulatory and quality executives the latest and best information on current trends. This year’s program will examine how the elections will impact Congressional action and FDA policies; updates on the UDI & IMDRF initiatives; and reports from the CDRH Ombudsman; and the local FDA offices. The program will also include a networking lunch and ample opportunities to meet with regulatory professionals from around the region.